RXST Net Income Growth
-45.57%TTM
Period ending:
RXST TTM Net Income YoY %%
158.05%-1018.02%
2021-12-312026-06-30
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
RXST net income growth history
Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 19 observations from Dec 31, 2021 to Jun 30, 2026.
| Period ending | Net Income Growth |
|---|---|
| -45.5662% | |
| -75.6903% | |
| -41.843% | |
| -16.4071% | |
| 12.2896% | |
| 40.343% | |
| 43.5175% | |
| 44.2343% | |
| 38.1418% | |
| 28.6603% | |
| 27.1856% | |
| 17.7019% | |
| 5.2459% | |
| -4.8621% | |
| -37.1069% | |
| -904.2042% | |
| -271.0473% | |
| -259.5836% | |
| -276.5694% |
Compare net income growth
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Brightspring Health Services Inc (BTSG) net income growth
- Ensign Group Inc (ENSG) net income growth
- Krystal Biotech Inc (KRYS) net income growth
- Protagonist Therapeutics Inc (PTGX) net income growth
- Tg Therapeutics Inc (TGTX) net income growth
- Healthequity Inc (HQY) net income growth
- Pacs Group Inc (PACS) net income growth
- Alkermes (ALKS) net income growth
Compare all covered stocks by net income growth →
All RXST financial metrics · RXST stock overview · How to interpret financial metrics
